These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3764377

  • 1. [Cyclosporin A in acute Crohn disease: initial findings].
    Marbet UA, Gyr K, Stalder GA.
    Schweiz Med Wochenschr; 1986 Jul 19; 116(29):962-3. PubMed ID: 3764377
    [Abstract] [Full Text] [Related]

  • 2. [Crohn disease: initial experiences with cyclosporin A in an adolescent girl].
    Dannecker G, Malchow H, Niessen KH, Ranke MB.
    Dtsch Med Wochenschr; 1985 Mar 01; 110(9):339-43. PubMed ID: 2857635
    [Abstract] [Full Text] [Related]

  • 3. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM, Rogler G, Gross V, Gierend M, Bregenzer N, Andus T, Schölmerich J.
    Am J Gastroenterol; 2002 Jun 01; 97(6):1438-45. PubMed ID: 12094862
    [Abstract] [Full Text] [Related]

  • 4. The steroid resistance of Crohn's disease.
    Mingrone G, DeGaetano A, Pugeat M, Capristo E, Greco AV, Gasbarrini G.
    J Investig Med; 1999 Jul 01; 47(6):319-25. PubMed ID: 10431487
    [Abstract] [Full Text] [Related]

  • 5. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).
    Aliment Pharmacol Ther; 2004 Dec 01; 20(11-12):1347-52. PubMed ID: 15606397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor/cachectin in Crohn's disease. Relation of serum concentration to disease activity.
    Sategna-Guidetti C, Pulitanò R, Fenoglio L, Bologna E, Manes M, Camussi G.
    Recenti Prog Med; 1993 Feb 01; 84(2):93-9. PubMed ID: 8465094
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H, Sophani I, Lemann M, Modiglani R, Solue JC.
    Turk J Gastroenterol; 2003 Jun 01; 14(2):121-7. PubMed ID: 14614639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
    Novacek G, Kleinberger M, Vogelsang H, Moser G, Lochs H.
    Z Gastroenterol; 1995 May 01; 33(5):251-4. PubMed ID: 7610692
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
    Korzenik JR, Dieckgraefe BK.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):391-400. PubMed ID: 15709989
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.